Genix Pharmaceuticals Corporation
GENX.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.50K | 112.80K | -60.00K | -63.30K | -43.70K |
| Total Depreciation and Amortization | -- | -- | -- | -- | 200.00 |
| Total Amortization of Deferred Charges | 200.00 | 200.00 | 200.00 | 200.00 | -- |
| Total Other Non-Cash Items | 33.60K | -165.70K | 24.00K | 24.20K | 11.40K |
| Change in Net Operating Assets | -2.80K | 23.20K | 2.20K | -4.20K | 600.00 |
| Cash from Operations | -44.40K | -29.60K | -33.50K | -43.10K | -31.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 54.80K | 41.60K | 46.60K | 58.70K | 40.20K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38.60K | 30.50K | 34.00K | 43.30K | 29.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.80K | 900.00 | 500.00 | 200.00 | -1.70K |